The pathogenesis of T2DM is characterized by the inflammatory component inducing progressive loss of β-cell insulin secretion with co-existing insulin resistance (16, 17), impacting early β-cell function and cell fate (18), where overweight and obesity are deemed the most effective “accelerator” (19) (Figure 1). The gene discussed is INS; the disease is Insulin resistance.